Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
Alberto AimoDomingo A Pascual FigalAntoni Bayes-GenisMichele EmdinGeorgios GeorgiopoulosPublished in: European journal of clinical investigation (2020)
Colchicine therapy near halves the risk of cardiovascular events in CCS compared with placebo and is associated with a nonsignificant 23% risk reduction in ACS, together with a trend towards a greater reduction of hs-CRP.
Keyphrases
- cardiovascular events
- coronary artery disease
- low dose
- cardiovascular disease
- liver failure
- acute coronary syndrome
- drug induced
- coronary artery
- high dose
- respiratory failure
- randomized controlled trial
- double blind
- hepatitis b virus
- atrial fibrillation
- mechanical ventilation
- study protocol
- transcatheter aortic valve replacement